News

In the field of artificial intelligence, there are many Swiss companies collaborating with research institutes that are renowned for their work in this sector. Zurich is an important hub for this. The first Swiss AI Report shows that this topic has become a priority for the economy.

Galgenen - Estée Lauder Companies is expanding its distribution network in Switzerland. The cosmetics company opened a new distribution center in Galgenen in the canton of Schwyz on 7 June. It is equipped to support the continued growth of the global Travel Retail business.

Schlieren - ImmunOs Therapeutics AG has raised 71 million francs in a funding round. With this, the biotech from the Greater Zurich Area will progress its lead candidate through Phase 2 clinical trials.

Zurich/Munich - Knorr-Bremse will in future benefit from the use of sensor technology and the digital ecosystem of Nexxiot. The relevant agreement for this strategic partnership has been concluded, with the German global market leader for braking systems now set to invest a sum of 60 million euros in the company based in the Greater Zurich Area.

Davos - Lab42 in the Greater Zurich Area is seeking to create the next generation of algorithms with human-level intelligence capable of solving problems for which - so far - no solution has been found. It will target the world’s leading experts in the field of Artificial Intelligence to take part in the ARC-2 Challenge, which is set to launch in the near future.

Zurich - With its new funding instrument known as Transform, the University of Zurich is providing two interdisciplinary research initiatives - One Health Research and the Center for Legal Data Science - with seed financing in the amount of 2.7 million Swiss francs over the next four years.

Schlieren - Oncobit, the MedTech start-up based in the Greater Zurich Area, has been awarded its first CE marking for a cancer treatment product. PM BRAFV600 is used to monitor the treatment response, residual disease and recurrence in melanoma patients.

Zurich - For the development of mechatronic systems, Helbling is advancing the use of a concept known as the digital twin. This allows Helbling specialists to carry out efficient, interdisciplinary collaborations in a digital environment, thereby also cutting development times.

Lugano - Healiva has acquired two cell therapy products to treat chronic wounds from the UK-based medtech company Smith+Nephew. The biotech company from the Greater Zurich Area also plans to establish one of the world’s most comprehensive portfolios for affordable, personalized wound care with this.